{"product_id":"juvederm-voluma-xc-1-ml-2syr-ships-to-medical-office-only","title":"JUVÉDERM VOLUMA XC 1 mL, 2syr (SHIPS TO MEDICAL OFFICE ONLY)","description":"\u003ch3\u003e\u003cstrong\u003ePLEASE ADVISE: Allergan requires a medical office to ship to. Please email inventory@hydrieght.com with this information to submit for approval before ordering. \u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eA smooth filler to restore age-related volume loss in the cheek area for natural-looking results that last up to 2 years with optimal treatment.\u003c\/p\u003e\n\u003cp\u003eTwo 1.0 ml syringes and two 27G ½\" needles per box.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eComposition:\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e20mg\/ml of cross-linked hyaluronic acid gel formulated with 0.3% lidocaine, in phosphate buffer at a neutral pH.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eTreatment Areas:\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCheek area in patients with moderate to severe age related volume loss of mid-face.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eJUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLUMA\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC injectable gel is available by prescription only.\u003c\/p\u003e\n\u003ch2\u003eJUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eCollection of Fillers Important Information\u003c\/h2\u003e\n\u003cp\u003e\u003cb\u003eINDICATIONS\u003c\/b\u003e\u003cbr\u003eJUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLUMA\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC injectable gel is indicated for deep (subcutaneous and\/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face, for augmentation of the chin region to improve the chin profile, and for supraperiosteal injection to augment the temple region to improve moderate to severe temple hollowing in adults over the age of 21.\u003c\/p\u003e\n\u003cp\u003eJUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLUX\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC injectable gel is indicated for subcutaneous and\/or supraperiosteal injection for improvement of jawline definition in adults over the age of 21 with moderate to severe loss of jawline definition.\u003c\/p\u003e\n\u003cp\u003eJUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLLURE\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC injectable gel is indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21.\u003c\/p\u003e\n\u003cp\u003eJUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLBELLA\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC injectable gel is indicated for injection into the lips for lip augmentation and correction of perioral rhytids, and for the improvement of infraorbital hollowing in adults over the age of 21.\u003c\/p\u003e\n\u003cp\u003eJUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eUltra Plus XC and JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eUltra XC injectable gels are indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).\u003c\/p\u003e\n\u003cp\u003eJUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eUltra XC injectable gel is also indicated for injection into the lips and perioral area for lip augmentation in adults over the age of 21.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eIMPORTANT SAFETY INFORMATION\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eCONTRAINDICATIONS\u003c\/b\u003e\u003cbr\u003eThese products should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in these products.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWARNINGS\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDo not inject into blood vessels. Introduction of these products into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft tissue fillers; for example, after insertion of the needle and just before injection, the plunger rod can be withdrawn slightly to aspirate and verify the needle is not intravascular, inject the product slowly, and apply the least amount of pressure necessary. Rare, but serious, adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms: changes in vision, signs of a stroke, blanching of the skin, unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and, possibly, evaluation by an appropriate healthcare professional specialist should an intravascular injection occur\u003c\/li\u003e\n\u003cli\u003eProduct use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003ePRECAUTIONS\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTo minimize the risk of potential complications, these products should only be used by healthcare professionals who are knowledgeable about the anatomy and the product(s) for use in indicated area(s), and who have appropriate training in facial anatomy, vasculature, safe injection techniques, and identification and management of potential adverse events, including intravascular complications\u003c\/li\u003e\n\u003cli\u003eThe potential risks of soft tissue injections should be discussed with patients prior to treatment to ensure they are aware of signs and symptoms of complications\u003c\/li\u003e\n\u003cli\u003eThe safety and effectiveness for the treatment of anatomic regions other than indicated areas for each product have not been established in controlled clinical studies\u003c\/li\u003e\n\u003cli\u003eThe safety for use of these products in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied\u003c\/li\u003e\n\u003cli\u003eThe safety for use during pregnancy and in breastfeeding females has not been established\u003c\/li\u003e\n\u003cli\u003eThe safety for use of JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLUMA\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC has been established in patients between 35 and 65 years of age for cheek augmentation, 22 and 80 years of age for chin augmentation, and 32 and 82 years of age for improvement of temple hollowing\u003c\/li\u003e\n\u003cli\u003eThe safety for use of JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eUltra Plus XC and JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eUltra XC in patients under 18 years, and the safety for use of JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLUX\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC, JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLLURE\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC, and JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLBELLA\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC in patients under 22 years, has not been established\u003c\/li\u003e\n\u003cli\u003eDermal filler implantation carries a risk of infection. Follow standard precautions\u003c\/li\u003e\n\u003cli\u003eDermal fillers should be used with caution in patients on immunosuppressive therapy\u003c\/li\u003e\n\u003cli\u003ePatients taking medications that can prolong bleeding (such as aspirin, nonsteroidal antiinflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites\u003c\/li\u003e\n\u003cli\u003ePatients who experience skin injury near the site of implantation may be at a higher risk for adverse events\u003c\/li\u003e\n\u003cli\u003eIf laser treatment, chemical peel, or any other procedure based on active dermal response is considered after treatment, or before skin has healed from a procedure prior to treatment, there is a possible risk of eliciting an inflammatory reaction at the injection site\u003c\/li\u003e\n\u003cli\u003eThe safety for use of JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLUMA\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC injectable gel in patients with very thin skin in the mid-face has not been established\u003c\/li\u003e\n\u003cli\u003eThe safety of using a cannula with JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLUMA\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC for cheek augmentation in patients with Fitzpatrick Skin Types V and VI or to improve temple hollowing has not been established\u003c\/li\u003e\n\u003cli\u003eJUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLUMA\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC was not evaluated in subjects with significant skin laxity of the chin, neck, or jaw in the chin augmentation study\u003c\/li\u003e\n\u003cli\u003eThe effect of JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLUMA\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC injection into the chin on facial hair growth has not been studied\u003c\/li\u003e\n\u003cli\u003ePatients may experience late-onset adverse events with injectable gel implants, and lateonset nodules with use of JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLUMA\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC\u003c\/li\u003e\n\u003cli\u003eBased on preclinical studies, patients should be limited to 20 mL of any JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003einjectable gel per 60 kg (132 lb) body mass per year. The safety of injecting greater amounts has not been established\u003c\/li\u003e\n\u003cli\u003eInjection of more than 9 mL of JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLUX\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC for improvement of jawline definition has not been studied\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eADVERSE EVENTS\u003c\/b\u003e\u003cbr\u003eThe most common reported side effects for JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003einjectable gels were redness, swelling, pain, tenderness, firmness, lumps\/bumps, bruising, discoloration, and itching. For JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eVOLBELLA\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eXC, dryness was also reported. The majority were mild or moderate in severity.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eTo report an adverse reaction with any product in the JUVÉDERM\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eCollection, please call Allergan\u003csup\u003e®\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003eProduct Support at 1-877-345-5372. Please visit\u003cspan\u003e \u003c\/span\u003e\u003ca href=\"https:\/\/www.rxabbvie.com\/\" title=\"Prescribing Information\"\u003erxabbvie.com\u003c\/a\u003e\u003cspan\u003e \u003c\/span\u003efor more information.\u003c\/b\u003e\u003c\/p\u003e","brand":"Allergan","offers":[{"title":"Default Title","offer_id":47532111822979,"sku":"94640","price":833.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0391\/6975\/3219\/files\/Voluma.png?v=1783706213","url":"https:\/\/ordering-portal.hydreight.com\/products\/juvederm-voluma-xc-1-ml-2syr-ships-to-medical-office-only","provider":"Digital Health Ordering Portal","version":"1.0","type":"link"}